Soleno Therapeutics, Inc. · NASDAQ:SLNO
Janus Henderson Group PLC reported a 13.40% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Janus Henderson Group PLC reported a 13.40% stake in Soleno Therapeutics, Inc., 7,178,354 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 13.40%
- Shares
- 7,178,354
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 13.40% | 7,178,354 |
Source
Related
- Soleno Therapeutics, Inc.
- Janus Henderson Group PLC
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 7, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026